To determine if the primary tumor response in patients with IR HPV-positive
OPSCC following 2 weeks of CRT is predictive of clinical outcomes.
To define the difference of the primary tumor response in patients with LR
HPV-positive OPSCC and HPV-negative OPSCC following 2 weeks of CRT
This project was funded by: combined funds from radiology and above fund acct
The term of this project was: September 2018 to August 2020
The number of subjects scanned during this project was: 58